248 related articles for article (PubMed ID: 10768570)
21. Cancer therapy using bone-seeking isotopes.
Lewington VJ
Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
[TBL] [Abstract][Full Text] [Related]
22. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
Sinzinger H; Weiss K; Hiltunen J
Anticancer Res; 2009 Aug; 29(8):3393-5. PubMed ID: 19661362
[TBL] [Abstract][Full Text] [Related]
23. Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.
Bruland OS; Skretting A; Solheim OP; Aas M
Acta Oncol; 1996; 35(3):381-4. PubMed ID: 8679270
[TBL] [Abstract][Full Text] [Related]
24. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.
Tian JH; Zhang JM; Hou QT; Oyang QH; Wang JM; Luan ZS; Chuan L; He YJ
Eur J Nucl Med; 1999 Jan; 26(1):2-7. PubMed ID: 9933654
[TBL] [Abstract][Full Text] [Related]
25. Strontium-89 for the palliation of bone pain due to metastatic disease.
Taylor AJ
J Nucl Med; 1994 Dec; 35(12):2054. PubMed ID: 7527458
[No Abstract] [Full Text] [Related]
26. Strontium and samarium therapy for bone metastases from prostate carcinoma.
Dickie GJ; Macfarlane D
Australas Radiol; 1999 Nov; 43(4):476-9. PubMed ID: 10901963
[TBL] [Abstract][Full Text] [Related]
27. Therapy of metastatic bone pain.
Serafini AN
J Nucl Med; 2001 Jun; 42(6):895-906. PubMed ID: 11390554
[TBL] [Abstract][Full Text] [Related]
28. Samarium-153-EDTMP biodistribution and dosimetry estimation.
Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
[TBL] [Abstract][Full Text] [Related]
29. Advances in our understanding of the treatment of painful bone metastasis.
Siberstein EB
J Nucl Med; 2000 Apr; 41(4):655-7. PubMed ID: 10809605
[No Abstract] [Full Text] [Related]
30. [Treatment of painful bony metastases with Samarium 153-EDTMP in prostate carcinoma].
Mhiri A; Hassad R; Sellem A; Bahri H; Diakite R; Slim I; Mahersi M; Hammami H; Ben Adallah M; Ben Slimene MF
Tunis Med; 2007 Jul; 85(7):580-5. PubMed ID: 18064991
[TBL] [Abstract][Full Text] [Related]
31. Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors.
Iakovou I; Doumas A; Badiavas K; Mpalaris V; Frangos S; Farmakis G
Cancer Biother Radiopharm; 2014 Apr; 29(3):116-23. PubMed ID: 24392878
[TBL] [Abstract][Full Text] [Related]
32. Samarium-153-EDTMP in bone metastases.
Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
[TBL] [Abstract][Full Text] [Related]
33. Procedure guideline for bone pain treatment: 1.0. Society of Nuclear Medicine.
Silberstein E; Taylor A
J Nucl Med; 1996 May; 37(5):881-4. PubMed ID: 8965169
[No Abstract] [Full Text] [Related]
34. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
Porter AT; Ben-Josef E; Davis L
Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
[TBL] [Abstract][Full Text] [Related]
35. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
[TBL] [Abstract][Full Text] [Related]
36. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
37. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
Handkiewicz-Junak D; Poeppel TD; Bodei L; Aktolun C; Ezziddin S; Giammarile F; Delgado-Bolton RC; Gabriel M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):846-859. PubMed ID: 29453701
[TBL] [Abstract][Full Text] [Related]
38. Radionuclide therapy in oncology.
Clarke SE
Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
[No Abstract] [Full Text] [Related]
39. Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Scher HI; Curley T; Yeh S; Tong W; O'Moore PV; Larson S
Adv Exp Med Biol; 1992; 324():115-29. PubMed ID: 1283494
[No Abstract] [Full Text] [Related]
40. EANM procedure guidelines for treatment of refractory metastatic bone pain.
Silberstein EB; Taylor AT;
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]